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Abstract
Background: Multiple sclerosis (MS) is consistently associated with particular HLA-DRB1-DQB1
haplotypes. However, existing evidence suggests that variation at these loci does not entirely
explain association of the HLA region with the disease. The MOG locus is a prime positional and
functional candidate for such additional predisposing effects but the analysis is complicated by the
strong, albeit labyrinthine pattern of linkage disequilibrium in the region. Here we have assessed
the association of MOG variation with MS in the Sardinian population to see if it represents an
independent contributor to MS predisposition.
Results: After re-sequencing the MOG gene in 21 healthy parents of MS patients we detected 134
variants, 33 of which were novel. A set of 40 informative SNPs was then selected and assessed for
disease association together with 1 intragenic microsatellite in an initial data set of 239 MS families.
This microsatellite and 11 SNPs were found to be positively associated with MS, using the
transmission disequilibrium test, and were followed up in an additional 158 families (total families
analysed = 397). While in these 397 families, 8 markers showed significant association with MS,
through conditional tests we determined that these MOG variants were not associated with MS
independently of the main DRB1-DQB1 disease associations.
Conclusion: These results indicate that variation within the MOG gene is not an important
independent determinant of MS-inherited risk in the Sardinian population.
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Background
Multiple sclerosis (MS) is a serious chronic inflammatory
and demyelinizating disorder of the central nervous sys-
tem which results from an autoimmune attack on compo-
nents of the oligodendrocyte cell [1]. The disease is more
common in European and European-derived popula-
tions. Within Europe it shows a north-south gradient,
with the notable exception of the Mediterranean island of
Sardinia, which has one of the highest prevalences world-
wide [2]. The disease risk for a monozygotic twin of an
affected patient is about 30%, showing a quick fall-off rate
with decreased genetic relatedness to affected individuals.
These data, and the increasing incidence of disease
reported in some populations over the last few decades
[3,4], suggest that the chance of this inflammatory process
occurring depends on the complex interplay between a
polygenic trait and unknown environmental factors influ-
encing the penetrance of susceptibility genes [5,6]. MS has
been found to be consistently associated with specific
HLA class II variants and notably with the HLA-
DRB1*1501-DQB1*0602 haplotype, which represents
the main risk factor for disease occurrence in different eth-
nic backgrounds [7-11]. The relative contribution of vari-
ation at the DRB1  and  DQB1  loci to disease
predisposition is still not completely clear although some
studies based on cross-comparing rare HLA DRB1-DQB1
haplotype splits have indicated that the main contribu-
tion comes from variation at the DRB1 locus [11]. Analy-
sis of large data sets from Finland and Canada have also
suggested that in those populations, any important addi-
tional modifiers of MS susceptibility were likely to be con-
tained in the regions close to DRB1 [12]. In Sardinia, the
HLA-DRB1*1501-DQB1*0602 haplotype is rare but is
still significantly positively associated with MS together
with an additional 4 haplotypes including DRB1*1303-
DQB1*0301, DRB1*0405-DQB1*0301, DRB1*0301-
DQB1*0201 and DRB1*0405-DQB1*0302 [13]. Some of
these haplotypes, such as DRB1*0301-DQB1*0201 are
also associated with MS in some non-Sardinian popula-
tions [11,14,15] but not in others [8,9,16-20]. The pres-
ence of HLA non-DRB1-DQB1 predisposing effects related
to a different distribution of extended HLA-DRB1*0301-
DQB1*0201 haplotypes in different populations can
explain these findings. Indeed, some studies have sug-
gested that within the HLA region there are further inde-
pendent predisposing effects determined by as yet
unidentified non-DRB1-DQB1 variants [13,21-24]. How-
ever, strong linkage disequilibrium (LD) between the var-
iants contained in the HLA region makes it difficult to
detect which polymorphisms, outside the exon 2
sequences of the DR/DQ loci but within the HLA region,
further influence disease risk. Within the HLA region, the
MOG gene is a prime candidate for additional MS associ-
ations. This gene is located, 2.9 Mb telomeric of the DRB1
locus, in a chromosome interval which has shown some
evidence of association with MS independent of DRB1-
DQB1 [13]. Furthermore, the rodent ortholog of this gene
encodes for an autoantigen which triggers autoimmune
responses in experimental models of disease [25,26].
Moreover, in MS patients both T-cell and antibody
responses against this protein have been detected [27,28]
and an aetiologic role of anti-MOG antibodies has been
suggested in acute lesions of MS patients [29], although
this role is controversial [30,31]. These findings could be
consistent with a model in which specific polymorphisms
in the MOG gene could determine amino acid variation or
differences in the level of expression of this protein in the
central nervous system and affect immune responses
against it, thus acting as primary aetiologic determinants
of disease pathogenesis.
A few studies have tested the association between MOG
polymorphisms and disease, with conflicting results.
Some of these studies indicated a potential role of MOG
[32,33] while others failed to find any evidence of primary
association with MS [34,35,12]. However, none of these
studies analysed the MOG  gene comprehensively, nor
assessed the association of genetic variation of this gene in
the context of extended DRB1-DQB1-MOG haplotypes.
The aim of this study was to establish the SNP content of
the MOG gene in the Sardinian population and use this
information together with appropriate conditional associ-
ation tests to assess the individual contribution of the
MOG gene to MS inherited risk to determine if it is an
important independent risk locus.
Results and discussion
In order to assess the association of MOG variation with
MS we first established polymorphism content of the
MOG gene in the Sardinian population by resequencing
the gene in 21 healthy parents of MS patients. The primers
used are listed in Table 1, and technical details are
reported in the Methods section. We detected 134 SNPs,
101 of which had already been reported [36] and 33 were
novel. A set of 40 informative SNPs was then selected to
be tested for disease association (see Methods). These
were initially genotyped in a data set of 239 MS families.
To identify the haplotype-tagging patterns, we computed
the intermarker D' and r2 values of these 40 informative
SNPs, computed for 478 parents of the MS patients,
shown in Figure 1. The physical positions, with base 1165
corresponding to the translation start site of MOG, and
other relevant information are indicated in Table 2. D' val-
ues indicate that these SNPs are part of the same linkage
disequilibrium block (average 0.97 between contiguous
marker pairs) that, as we have previously shown, encom-
passes HLA class I and III sub-regions and also includes
the HLA class II DR and DQ loci [37,13]. As expected, con-
sidering selected SNPs were chosen in order to avoidBMC Genetics 2007, 8:25 http://www.biomedcentral.com/1471-2156/8/25
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genetically redundant markers, the r2 values showed rela-
tively low values with an average of 0.13 between contig-
uous marker pairs (Figure 1).
We then assessed disease association of the 41 variants of
interest, including these 40 SNPs of interest and the
MOG51 microsatellite, in a sample set of 239 families
using the extended transmission disequilibrium test
(ETDT). Without taking linkage disequilibrium with vari-
ation at the HLA-DRB1-DQB1 loci into account, 11 SNPs
-SNP07 (novel), SNP06 (novel), SNP05 (novel),
rs2071652, rs2857767, SNP04 (novel), rs2535260,
rs2535261, SNP03 (novel), rs2252734, rs29228 and the
MOG51 microsatellite showed evidence of association at
a significance level of 5% with MS (data not shown). We
then evaluated MS association of these markers in an
additional 158 MS families (total n = 397 families). In this
larger sample set, 8 markers showed some evidence of
association at 5% significance level (Figure 2) with one
haplotype defined by variants at rs2071652 (allele C),
rs2857767 (allele C) and rs2535260 (allele C) showing
the strongest disease association (P = 3.29 × 10-6). This
level of significance was slightly lower than that shown by
association of HLA-DRB1 (P = 7.9 × 10-7) and -DQB1 in
the same sample set (P = 1.3 × 10-7). The transmission
data of these variants individually and in the context of
the three locus DRB1-DQB1-MOG haplotypes are shown
in the online appendix along with the D' values among
MOG variants and the various DRB1-DQB1 haplotypes.
The eight disease associated variants are essentially part of
two main LD blocks formed, on the one hand by
rs2071652, rs2857767 and rs2535260 and on the other
hand by the other five variants. From these data it is evi-
dent that while SNP07, SNP06; SNP04, SNP03 are in pos-
itive LD only with the DRB1*0301-DQB1*0201
haplotype, SNPs rs2071652, rs2857767 and rs2535260
occur frequently (albeit at different degrees of positive LD
from strong to modest) and show a significant association
with more than one HLA-DRB1-DQB1 haplotype. The co-
occurrence of these MOG variants with different DRB1-
DQB1 haplotypes could just be a chance event or could be
due to any of the various forces which impact LD [37].
Importantly, we also assessed the disease association of
MOG alleles which individually showed significant evi-
dence of association with MS together with the other
DRB1-DQB1 haplotypes grouped (that is, all DRB1-DQB1
haplotypes which did not show any evidence of signifi-
cant association with MS). These extended DRB1-DQB1-
MOG haplotypes showed a consistent negative transmis-
sion from parents to affected patients (see Additional file
1). This suggested that MOG  disease associations were
most likely driven by DRB1-DQB1 variation.
Next, we wanted to directly assess whether these MOG
associations were independent from DRB1-DQB1 associ-
ations. To this end, we analysed the overall effect of allelic
and haplotype variation at the MOG gene using the con-
ditional ETDT (CETDT) [38]. Using this conditional anal-
ysis, which takes into account linkage disequilibrium
between overall MOG variation and overall variation at
the HLA-DQB1 and -DRB1 loci, MOG associations were
no longer significant. Conversely, the overall associations
of DRB1-DQB1 haplotypes, taking into account the most
associated MOG haplotype, gave a P value of 9.7 × 10-3.
We also evaluated the relative transmission of the MOG
alleles and haplotypes according to which specific DRB1-
DQA1-DQB1 haplotypes they were on (Figure 3). In order
to carry out these analyses we used the haplotype method
(HM)-TDT (Methods) [39]. Using this test we initially
evaluated association of specific variants of MOG, taking
into account linkage disequilibrium with the HLA-DRB1-
DQB1  haplotypes for which there is prior evidence of
association with MS in the Sardinian population (i.e.
DRB1*1303-DQB1*0301, DRB1*0405-DQB1*0301,
DRB1*0301-DQB1*0201, DRB1*1501-DQB1*0602 and
DRB1*0405-DQB1*0302 haplotypes) [13]. Again, allelic
variation at the MOG locus did not significantly affect the
transmission of these predisposing DRB1-DQB1 haplo-
types (Figure 3). Also the MOG  haplotype defined by
rs2071652, rs2857767 and rs2535260 did not produce
Table 1: 
Primers Forward 5'-3' Reverse 5'-3' TM
1 atgcaacagggagaaagagc gaccagcattggtagcaggt 57°C
2 tggacagcacggctctaaat tggacagcacggctctaaat 58°C
3 ggtctggtgatgacagttgtg ggaagggaggcatgtcagta 60°C
4 tgtattttagtacagacggggtttc tggtgcctgattatgcagag 60°C
5 gcttagcagtgcctgtccat gccaaattgctgcctattct 58°C
6 agggtggaagatctcagaag caaagcgctgggattatg 57°C
7 gctgaggcaggagaatcact ttggccacccaacagttaat 59°C
8 aaataaaaaggaagaagaagaaga ccacccaacagttaataccta 57°C
9 ggcagcaatggaattgaaag cccacagtgctgggattac 58°C
10 ccaggggtttgcagttacag gcttattcactaggaccaagcac 57°C
11 ttgcagtgagccaaaatcc tcacccatcatgcaaaacat 63°C
12 tgacctcaggtgatccactc ggtgaaactgagggagtttg 62°C
13 tgagaccctctccagtttgc agacgaagaggtgggaacag 60°C
14 tcacatcttacaaactcaacaaaaa ccaggagggttgcttaggta 59°C
15 ccagtctggcctcgagaact tcacaaatattggccaggtg 59°C
16 ccagtcctgtaggtgctaaa cttagccctgaaggaaaaat 56°C
17 tctaaatcactagcatttcctg gaaagcattccgtaagatgt 58°C
18 tgggttcagaagttcttctcacta ccccataccctccttgctac 62°C
19 gccagagcaggaagagtc cgttgccactttgtttatc 56°C
20 gctactcactaaatgttcagctcct cttgttcccccaggtgact 62°C
21 ctccaccggacttttggtaa ggtgctcttctgttgccatt 57°C
22 gaattgacccctcaaggaca aggcagaggtttcagtgagc 61°C
23 ggcagagttttgctcttgtca tggtgaaaccccgtctctac 58°C
24 agtgcaggggcaggatct gcatggggacagaggaataa 58°C
25 ccttttctcttcattttcccatt ggatgagaggaaggaaagattc 59°C
26 tgcctgctttagaatgttttcc agacaggtgcgtggataagg 59°C
27 aagttttcataagcacacttctaacc tctctccagacaccagaagg 61°CBMC Genetics 2007, 8:25 http://www.biomedcentral.com/1471-2156/8/25
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significant evidence of primary association when analysed
with the HM-TDT conditional on DRB1-DQB1 positively
associated haplotypes (data not shown). Moreover, we
also conducted the HM-TDT to assess whether these MOG
variants were influencing association of the non-predis-
posing DRB1-DQB1 haplotypes grouped. No significant
heterogeneity in the association of DRB1-DQB1 haplo-
type conditional on MOG was seen, again suggesting that
the initial observations of association with MS risk were
likely to be only a consequence of LD with the DR-DQ
mediated MS risk. This is shown in Figure 3, Graph F.
Considering our results globally, they provide evidence
that haplotypes identical at the DRB1-DQB1 loci but dif-
ferent at the MOG locus do not have different associations
with MS. Thus the significant association of MOG alleles
and haplotypes appear to be secondary to hitchhiking
effects due to variation at the DRB1-DQB1 loci. In inter-
preting these results it should be considered that the HLA
region as a whole confers only a relatively modest contri-
bution to the familial clustering and to the individual
inherited risk of MS. Thus, the statistical power required to
rule out a rare disease variant not detected in our rese-
quencing, or even more dramatically, one that only
slightly modulates the disease risk conferred by HLA-
DRB1-DQB1  variants would require unrealistic sample
sizes which exceed those used in this study. Still, our
results and conclusions are consistent with those obtained
in other populations [40], although there is still the sug-
gestion that other non-DR-DQ genes may convey an inde-
pendent risk to MS [41,42,12,24].
The genetic results presented here have relevant mechanis-
tic biological implications because they suggest that the
protein product of the candidate gene MOG is unlikely to
represent the primary autoantigen in human MS and thus
cannot explain the target organ specificity observed in this
disease. Contrast these data with the primary and consist-
ent association detected with variation in the insulin gene
(INS) region in type 1 diabetes and the epistatic devia-
tions from a multiplicative model detected in the joint
analysis of HLA class II and INS [43].
Conclusion
From our results we can conclude that variation at the
MOG gene does not provide a significant independent
contribution to the inherited risk for MS in the Sardinian
population. The data suggests that the protein product of
Distribution of r2 and D' intermarker values (above and below the diagonal respectively) for 40 SNPs analysed in 478 parents  of Sardinian MS patients Figure 1
Distribution of r2 and D' intermarker values (above and below the diagonal respectively) for 40 SNPs analysed in 478 parents 
of Sardinian MS patients.BMC Genetics 2007, 8:25 http://www.biomedcentral.com/1471-2156/8/25
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MOG is unlikely to represent the primary autoantigen in
human MS.
Methods
Study participants
In the study we considered a sample set of 397 independ-
ent MS families, which included 391 trios families (one
affected child and both healthy parents), 4 multiplex fam-
ilies (more than one affected sibling and their healthy par-
ents) and 2 vertical families (one parent and one affected
offspring), all being at least third generation Sardinian.
This data set of 397 MS families is a proper subset of the
490 Sardinian MS families described previously [13]. All
patients met the criteria of definite MS [33]. The average
age of onset for MS was 28.9 years (range 6 – 51 years),
and the female/male ratio was 2.3. The disease course was
relapsing-remitting in 65%, secondary progressive in 27%
and primary progressive in 8% of patients. All families
had previously been analysed at the DRB1-DQA1-DQB1
loci [13].
Power calculations
To examine the feasibility of verifying whether variants in
the MOG gene, or in strong LD with it could explain the
association peak that was previously observed in Sardinia
[13], we focused on the parent-affected child trios that we
had already studied during the initial examination of the
role of the HLA in MS susceptibility. We postulated that
our search would be for a fairly common variant (in line
with the frequency of the predisposing DRB1-DQB1 hap-
lotypes) with a maximal relative risk of 1.9 and using a
disease prevalence of 0.0014 (corresponding to the preva-
lence in Sardinia). The strength of LD between the DRB1-
DQB1 locus and MOG was estimated at a mean value of
r2 = 0.3 as previously shown [13]. Purcell and Sham power
calculations for our 391 trios gave for an alpha value of
0.10 a power of 0.83 [44]. It should be noted that for the
conditional analyses, in the case of conditioning on the
absence of high-risk HLA haplotypes, the trio size is 121
and the corresponding power is reduced to 0.42 for the
same alpha criteria.
MOG polymorphism analysis
We resequenced the MOG  gene in 21 parents of MS
patients heterozygous for the 226 bp allele at the MOG51
microsatellite locus, which was found to be significantly
associated with MS [13]. This selection of informative par-
ents increases the chance of detecting relevant polymor-
phisms. 37 overlapping fragments covering the whole
gene (8 exons and 7 introns) and -384 and 545 bp 5' and
3' from the transcriptional unit were amplified and capil-
lary sequenced (Megabace 1000). Overall, 16,561 bp were
sequenced. Primers were designed according to the pub-
lished human genomic DNA sequence [34] and are listed
in Table 1). PCR was carried out in a final volume of 25 µl
using a specific combination of primers and 5 µl of 4 ng/
µl genomic DNA. After an initial denaturation of 4 min-
utes at 95°C, there were 37 cycles at 95°C for 30 seconds,
at the specific TM primer for 30 s, 72°C for 30 s and a final
extension at 72°C for 7 minutes.
A set of 40 informative SNPs was selected and dot-blot
genotyped in the family sample set, using the set of prim-
ers listed in Table 1 and the SSO probes reported in Table
2. Selection of these SNPs was based on the patterns of LD
(in order to provide good map coverage and avoid geno-
typing and testing genetically redundant variants), on the
position in the gene (in order to maximise the chance of
testing functionally relevant variants) and on the minor
allele frequency (MAF) (in order to exclude particularly
rare variants for which we did not have sufficient statisti-
cal power in the subsequent association stage).
In addition to these SNPs, in this manuscript we also
assessed the association of MS with 1 intragenic microsat-
ellite, MOG51 [34], whose primer sequences have been
previously reported [13].
Statistical analysis
Single-point disease association of individual MOG vari-
ants as well as HLA-DRB1, DQB1 alleles was evaluated
using ETDT [45]. This test takes into account the transmis-
sion or non-transmission of alleles of a locus relative to
those present on the other parental chromosome. In the
case of multiallelic markers, the ETDT takes multiple alle-
ETDT analysis in 397 MS families Figure 2
ETDT analysis in 397 MS families. Single-point association of 
1 microsatellite and 8 SNP markers with MS within the MOG 
gene. Distances are given in Kb proceeding from the most 
centromeric marker, SNP07, to the most telomeric, SNP03. 
Association is presented as the negative log of the P-value for 
the extended transmission disequilibrium test (ETDT). The 
bold horizontal line corresponds to the threshold significance 
of 0.05BMC Genetics 2007, 8:25 http://www.biomedcentral.com/1471-2156/8/25
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Association analysis of 8 MOG variants with MS conditional on DRB1-DQB1 haplotypes using the Haplotype Method TDT Asso- ciation analysis of 8 MOG variants with MS conditional on DRB1-DQB1 haplotypes using the Haplotype Method-Transmission  Disequilibrium Test HM-TDT [39] Figure 3
Association analysis of 8 MOG variants with MS conditional on DRB1-DQB1 haplotypes using the Haplotype Method TDT Asso-
ciation analysis of 8 MOG variants with MS conditional on DRB1-DQB1 haplotypes using the Haplotype Method-Transmission 
Disequilibrium Test HM-TDT [39]. The 8 MOG variants are the same shown in Figure 1 while the 5 predisposing DRB1-DQB1 
haplotypes refer to DRB1*0301-DQB1*0201 (2A), DRB1*0405-DQB1*0301 (2B), DRB1*1303-DQB1*0301(2C), DRB1*0405-
DQB1*0302 (2D) and DRB1*1501-DQB1*0602 (2E), with DRB1*-DQB1* families negative for MS haplotypes that showed 
prior evidence of association with MS (2F) [13]. Association is presented as the negative log of the P-value for the extended 
transmission disequilibrium test (ETDT). The bold horizontal line corresponds to the threshold significance of 0.05BMC Genetics 2007, 8:25 http://www.biomedcentral.com/1471-2156/8/25
Page 7 of 10
(page number not for citation purposes)
Table 2: 
Position MAF (%) SNPs N. PCR (bp) T.A. Primer set (from Table 1) SSO probe
-84 9.9 1 rs29228 5' 613 A/G 57°C 1 cggacaaaaAcagaaatgt
290 5.6 2 rs29234 5' 525 A/C 58°C 2 agctgagccAagaggtgag
1179 6.0 3 rs3130250 Ex1 762 G/A 60°C 3 agcttatcGagaccctct
1715 23.0 4 rs2262263 Intr1 509 A/G 60°C 4 cccgcctcAgcttcccaa
2498 7.3 5 rs2252711 Intr1 508 T/C 58°C 5 gagagacagTtaaagtaga
2553 4.2 6 rs9257932 Intr1 408 T/C 57°C 6 ggcagcaatTtggccaagt
2582 1.6 7 SNP01(novel) Intr1 408 G/A 57°C 6 aggcccataGgaggattca
2925 1.7 8 SNP02(novel) Intr1 706 A/G 59°C 7 attagctggAtgcggcggt
3129 22.8 9 rs2252734 Intr1 568 C/G 57°C 8 gaagaaCaattgcaatc
4210 12.6 10 SNP03(novel) Intr2 642 G/A 58°C 9 gcccagcgccgtGgctc
4217 10.5 11 rs3095294 Intr2 642 A/G 58°C 9 ctcacAcctgtaatccca
4413 14.5 12 rs2535262 Intr2 507 G/A 57°C 10 gtgaacccGgaagcggag
4482 17.7 13 rs2535261 Intr2 507 G/A 57°C 10 cagcgagactccGtctca
4521 9.8 14 rs9257933 Intr2 507 G/A 57°C 10 gtatttgtgagcgcGcac
4617 7.0 15 rs3135050 Intr2 580 T/C 63°C 11 gagatgtcacTttttggc
4799 35.9 16 rs3095292 Intr2 580 G/A 63°C 11 ccgagtagctgGgattac
5062 20.9 17 rs2535260 Intr2 584 C/G 62°C 12 aggtgaagcCgatggagg
5523 10.6 18 rs3130251 Intr2 518 C/T 60°C 13 cacctataaCcccaaaac
7769 1.1 19 rs2857783 Intr2 569 T/C 59°C 14 acttgaaagTaaaggtag
9199 47.4 20 rs2535253 Intr2 591 A/C 59°C 15 attacaggaAtgtgccacc
9875 16.3 21 SNP04(novel) Intr2 404 A/G 56°C 16 ccttgagggActtcagat
10230 10.3 22 rs2857766 Ex3 493 G/C 58°C 17 tcctgcagatcactGttg
10239 1.1 23 rs3130253 Ex3 493 G/A 58°C 17 ttggcctcGtcttcctct
10495 4.4 24 rs2857767 Intr3 573 C/G 62°C 18 taactatgCcatatagtaa
10738 1.3 25 rs2857768 Intr3 573 T/C 62°C 18 ttgtttcctcTttctccat
10844 6.7 26 rs2535249 Intr3 573 A/G 62°C 18 tctccccaAtgccagagca
11154 4.5 27 rs17184486 Intr3 493 A/G 56°C 19 gattctccAagcttcagtt
11195 5.3 28 rs2857771 Intr3 493 C/T 56°C 19 aacatcctCcctcctaaat
11197 5.3 29 rs2535247 Intr3 493 C/G 56°C 19 aacatcctccCtcctaaat
11544 12.9 30 rs2071652 Intr3 740 C/T 62°C 20 ccaggctgCagagaaatag
11735 11.6 31 rs17184521 Intr4 740 G/A 62°C 20 aaatggtcccGttcttgga
12155 36.3 32 rs2071653 Intr5 583 C/T 57°C 21 tacaaaaaCgttatcttat
12556 9.2 33 SNP05(novel) Intr5 614 C/A 61°C 22 cagatggtaCcttctctga
12636 17.6 34 rs2535246 Intr5 614 T/G 61°C 22 cacagagTtctatcgtacg
13049 22.2 35 rs2535245 Intr5 545 T/C 58°C 23 ctcagcctccTgagtagct
13937 35.8 36 rs3095291 Intr5 713 G/C 58°C 24 cacgcccaGctaattttta
15643 13.9 37 SNP06(novel) Ex8 527 G/A 59°C 25 tgtgaaggGaaggaagagg
16003 11.8 38 rs9257936 Ex8 593 C/T 59°C 26 gataCgagttttggccggg
16248 6.2 39 rs3135049 Ex8 593 C/T 59°C 26 agctgagatcgCgccactg
16457 13.8 40 SNP07(novel) 3' 569 A/G 61°C 27 attaccccagAggtcagtcBMC Genetics 2007, 8:25 http://www.biomedcentral.com/1471-2156/8/25
Page 8 of 10
(page number not for citation purposes)
les into account and obtains a global P value indicative of
the degree of significance of the association with the dis-
ease at each individual locus. In order to distinguish pri-
mary associations from those due to linkage
disequilibrium at the various assessed loci, we used a var-
iant of the ETDT, called CETDT [38]. This test allows us to
analyse the overall effect of one locus, in our case MOG,
taking the overall association of variation at other loci
into account; in this study DRB1 and DQB1. In order to
study the transmission of specific MOG  alleles, condi-
tioned on alleles or haplotypes at the DRB1-DQB1 disease
loci, we used a TDT variant of the haplotype method [46];
the HM-TDT [39]. This method tests the null hypothesis
of equality of transmission of haplotypes identical at one
variant or combination of variants, but different at
another closely-linked test locus [39]. If there is heteroge-
neity in the transmission of two marker haplotypes iden-
tical at a predisposing marker (variant A) but different at
a putative predisposing marker at another site (variant B),
then this is evidence that variant A does not entirely
explain disease predisposition and that variant B itself, or
another marker in linkage disequilibrium with variant B,
is influencing the transmission of variant A and, thus, dis-
ease susceptibility [39].
LD between individual SNPs at the MOG  gene was
assessed computing the D' and r2 values. Both measures
are built on the basic pairwise-disequilibrium coefficient,
D, described by Lewontin [47], representing the difference
between the probability of observing two marker alleles
on the same haplotype and observing them independ-
ently in the population. The D and normalised disequilib-
rium D', or |D/Dmax|, values were computed on parental
haplotypes using the software package [48]. A value of D'
equal to 0.0 implies complete independence, whereas 1.0
implies that all copies of the rare allele occur exclusively
with one of the two possible alleles at the other assessed
marker.  R2, computed using a programme written by
Jason Cooper, assesses not only LD between two markers
but also the degree of matching between all allelic fre-
quencies of both SNPs [49], thus encompassing the effects
of both D and all marker allele frequencies. As for D', an
r2 value of 0.0 also implies independence, but r2 = 1.0
occurs only when the marker loci have identical allele fre-
quencies and every occurrence of an allele at each of the
markers perfectly predicts the allele at the other locus (i.e.
in the presence of genetically indistinguishable makers).
The two LD measures have different features: D' levels are
useful to define the extent of LD, for instance to establish
the presence of the so-called LD blocks along chromo-
some intervals. Instead, r2 are useful to establish marker
informativity and the degree of genetic redundancy
between selected SNPs and thus determine map coverage
[49].
For all analyses performed in this manuscript, haplotypes
were established following the co-segregation of alleles
within families and using computer programmes written
by F. Dudbridge and B. Koeleman. Only haplotypes show-
ing definitive parental genotype data are considered in the
analyses shown in this paper. In those families with more
than one affected patient, only the probands were evalu-
ated.
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